From Proteopedia
(Difference between revisions)
proteopedia linkproteopedia link
|
|
| Line 1: |
Line 1: |
| - | [[Image:1bln.gif|left|200px]] | + | {{Seed}} |
| | + | [[Image:1bln.png|left|200px]] |
| | | | |
| | <!-- | | <!-- |
| Line 9: |
Line 10: |
| | {{STRUCTURE_1bln| PDB=1bln | SCENE= }} | | {{STRUCTURE_1bln| PDB=1bln | SCENE= }} |
| | | | |
| - | '''ANTI-P-GLYCOPROTEIN FAB MRK-16'''
| + | ===ANTI-P-GLYCOPROTEIN FAB MRK-16=== |
| | | | |
| | | | |
| - | ==Overview==
| + | <!-- |
| - | Monoclonal antibody MRK-16 recognizes a discontinuous extracellular epitope on the multidrug resistance-associated ATP-binding cassette transporter, P-glycoprotein. The atomic basis for specificity of this antibody is of interest because of its potential as a modulator of P-glycoprotein activity. The crystal structure of Fab MRK-16 is reported to a resolution of 2.8 A. A structure for a portion of the epitope was derived by comparison to regions of solved structures with similar primary sequence. This has permitted a proposal for the mode of binding of the peptide epitope to the antibody, in which the peptide makes specific contacts with complementarity-determining regions H1, H2, and H3 from the heavy chain and L3 from the light chain. These interactions are consistent with epitope mapping studies and with the observation that MRK-16 is specific for human class I P-glycoprotein. This result identifies side chains in MRK-16 that would be amenable to alteration in antibody engineering experiments to derive improved multidrug resistance inhibitors for clinical use during chemotherapy. In particular, Arg-H97 contacts both Glu-746 and Asp-744 of the peptide, Arg-L96 contacts Asp-743, and Thr-H33 interacts with Thr-747. All of these epitope residues were implicated in mediating specificity by epitope mapping studies.
| + | The line below this paragraph, {{ABSTRACT_PUBMED_9738009}}, adds the Publication Abstract to the page |
| | + | (as it appears on PubMed at http://www.pubmed.gov), where 9738009 is the PubMed ID number. |
| | + | --> |
| | + | {{ABSTRACT_PUBMED_9738009}} |
| | | | |
| | ==About this Structure== | | ==About this Structure== |
| Line 24: |
Line 28: |
| | [[Category: Vasudevan, S.]] | | [[Category: Vasudevan, S.]] |
| | [[Category: Immunoglobulin]] | | [[Category: Immunoglobulin]] |
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri May 2 11:40:27 2008'' | + | |
| | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jun 30 19:21:19 2008'' |
Revision as of 16:21, 30 June 2008
Template:STRUCTURE 1bln
ANTI-P-GLYCOPROTEIN FAB MRK-16
Template:ABSTRACT PUBMED 9738009
About this Structure
Full crystallographic information is available from OCA.
Reference
Mode of binding of anti-P-glycoprotein antibody MRK-16 to its antigen. A crystallographic and molecular modeling study., Vasudevan S, Tsuruo T, Rose DR, J Biol Chem. 1998 Sep 25;273(39):25413-9. PMID:9738009
Page seeded by OCA on Mon Jun 30 19:21:19 2008
